HOME >> MEDICINE >> NEWS
Viagra improves urinary tract symptoms in men with erectile dysfunction

Viagra (sildenafil citrate), known for improving erectile dysfunction (ED), also effectively treats the prostate and lower urinary tract symptoms (LUTS) associated with prostate enlargement that often occur with ED, a Northwestern University study has found.

Kevin V. McVary, M.D., professor of urology at Northwestern University Feinberg School of Medicine, led the study, which he presented at a meeting of the Sexual Medicine Society of North America on Nov. 21 in New York.

McVary and members of the clinical trial conducted the 12-week, double-blind, placebo (fake pill)-controlled study of Viagra in men aged 45 years and older who had ED and LUTS associated with benign prostatic hyperplasia (BPH), an enlargement of the prostate gland that causes an obstruction in the flow of urine through the urethra.

Study participants were assessed for changes in erectile function, self-esteem, LUTS associated with BPH, quality of life and maximum urinary flow rate. Results of the study showed that men who took Viagra (either at bedtime or 30 minutes to an hour before anticipated sexual activity) experienced a significant improvement in erectile function, self-esteem and quality of life, with a concomitant decrease in both the irritative and obstructive symptoms of BPH.

More than half of men over 40 years have difficulties getting or maintaining and erection. Over half of men 50 years and older have some sign of BPH. Research has shown that more than 70 percent of men with symptoms of BPH also have ED.

Results of this study have important implications with respect to the causes of concomitant prostate symptoms and ED.


'"/>

Contact: Elizabeth Crown
e-crown@northwestern.edu
312-503-8928
Northwestern University
21-Nov-2005


Page: 1

Related medicine news :

1. Viagra, unlikely tool for vision research, slows the visual response to flickering light
2. Viagra blunts effects of stress on the human heart
3. Sildenafil (Viagra) approved for treatment of pulmonary arterial hypertension (PAH) as Revatio
4. U of M report says early-childhood intervention improves well-being through young adulthood
5. When minority patients have insurance and a medical home, their health care improves
6. Sleep Slide-Rule improves childrens understanding of the importance of sleep
7. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
8. Phase II study shows combination improves survival of metastatic melanoma patients
9. Adding medication improves recovery for elderly with depression, says Pitt School of Medicine study
10. New device for stroke patients improves walking
11. Employee health program improves blood pressure, diabetes control

Post Your Comments:
(Date:4/25/2015)... 25, 2015 The Hon. Ellen Tauscher, ... issues the following statement following the deadly earthquake in ... Nepal, resulting in the deaths of more than 1,000 ... felt across Nepal, Bangladesh, India and other parts of ... condolences to the people of Nepal and the families ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 By definition, a ... data for the enterprise relying on their judgement and expertise ... But according to an article published in National ... times actually be doing a disservice to their responsibilities by ... dotted and t’s are crossed when it comes to company ...
(Date:4/25/2015)... 25, 2015 Parker and Sons projects growth ... has spiked in Arizona alongside the growing economy. As a ... employees for April to help account for the rising need ... in April is something we are enthusiastic about. It means ... Kelly, president at Parker and Sons. , Indeed, Parker and ...
(Date:4/25/2015)... For thirteen years, the Twin Cities DI Day has been ... nation! This year, on May 5th, 2015, Secura Consultants is ... Day on the road by supporting the first ever National ... CLTC, Chief Executive Officer at Secura Consultants and co-creator of ... stating, "The first Twin Cities DI Day was a hugely ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 As the ... and the unique sacrifices of these young men and ... Service members, Veterans and their Families” presents a special ... is designed to gain a better understanding of the ... and wellness. For those – civilian and military – ...
Breaking Medicine News(10 mins):Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:Parker and Sons Plans to Expand in 2015 2Health News:Secura Consultants Takes DI Day On The Road 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2
(Date:4/23/2015)...  AbbVie (NYSE: ABBV ) has announced that ... its New Drug Application (NDA) and granted priority review ... of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The ... genotype 4 (GT4) hepatitis C virus (HCV) infection. ... being evaluated by the FDA for patients in ...
(Date:4/23/2015)... , April 23, 2015 Once again, ... strengthening our commitment to patient safety. BeaconMedaes, ... fight against infectious disease. The next generation ... Medical gas sensors are now mounted in the assembly, ... need to open ceiling tiles potentially releasing dust spores ...
(Date:4/23/2015)... FRANCISCO , April 23, 2015 Nektar Therapeutics ... the first quarter ended March 31, 2015 on Thursday, April ... Howard Robin , president and chief executive officer, will host ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... the conference call can be accessed through a link that ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2
Cached News: